Identification of therapeutic targets and prognostic biomarkers among CC chemokines in the pancreatic adenocarcinoma microenvironment

Identification of therapeutic targets and prognostic biomarkers among CC chemokines in the pancreatic adenocarcinoma microenvironment

Pancreatic adenocarcinoma (PAAD), one of the most aggressive and lethal malignant tumors, is correlated with increased morbidity and mortality. CC chemokines can modulate the infiltration of immune cells and affect the clinical outcome of cancer patients. However, the therapeutic potential and progn...

Full description

Bibliographic Details
Main Authors:	Xinyuan Liu, Qi Zhang, Tao Mao, Congcong Min, Jing Guo, Cuiping Zhang, Zibin Tian, Xiaoyu Li
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2023-04-01
Series:	Gastroenterology & Endoscopy
Subjects:	Pancreatic adenocarcinoma CC chemokines Prognosis Cytokines Tumor microenvironment
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949752322000073

Similar Items

CC chemokines and receptors in osteoarthritis: new insights and potential targets
by: Yuchen Zhang, et al.
Published: (2023-07-01)

CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis
by: APMP Marino, et al.
Published: (2005-03-01)

CC chemokines Modulate Immune responses in Pulmonary Hypertension
by: Qian Yan, et al.
Published: (2024-09-01)

CC chemokine receptors are prognostic indicators of gastric cancer and are associated with immune infiltration
by: Xinghe Liao, et al.
Published: (2024-01-01)

The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review
by: Toufik Abdul-Rahman, et al.
Published: (2024-02-01)

The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy
by: Erica C. F. Yeo, et al.
Published: (2021-03-01)

The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses
by: Mojgan Noroozi Karimabad, et al.
Published: (2022-08-01)

Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer
by: Yanhua Jing, et al.
Published: (2022-04-01)

CC-chemokine ligand 18, CXC motif chemokine 13 and osteopontin as biomarkers of silicosis and asbestosis: a prospective observational study
by: Na Wu, et al.
Published: (2025-02-01)

CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling
by: Yuan Nie, et al.
Published: (2023-02-01)

CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential
by: Shanshan Liu, et al.
Published: (2023-02-01)

Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer
by: Maria E. Reyes, et al.
Published: (2020-05-01)

Immunohistochemical Evaluation of the Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma
by: Gelu Mihai Breaza, et al.
Published: (2025-03-01)

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma
by: Bo Chen, et al.
Published: (2021-11-01)

AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma
by: Guo Chen, et al.
Published: (2022-05-01)

Flagellin Restricts HIV-1 Infection of Macrophages through Modulation of Viral Entry Receptors and CC Chemokines
by: Lina Zhou, et al.
Published: (2024-06-01)

Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status
by: E.B. Faber, et al.
Published: (2024-06-01)

Focus on Pancreatic Cancer Microenvironment
by: Fabiana Pratticò, et al.
Published: (2024-07-01)

Intratumoral microbiota of pancreatic ductal adenocarcinoma impact patient prognosis by influencing tumor microenvironment
by: Jingze Leng, et al.
Published: (2024-09-01)

Role of CC chemokine CCL6/C10 as a monocyte chemoattractant in a murine acute peritonitis
by: Andrew M. LaFleur, et al.
Published: (2004-01-01)

Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
by: Wenyu Luo, et al.
Published: (2024-01-01)

The tumor–stroma ratio and the immune microenvironment improve the prognostic prediction of pancreatic ductal adenocarcinoma
by: Mei Lu, et al.
Published: (2023-07-01)

The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma
by: Di Wang, et al.
Published: (2023-06-01)

Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma
by: Jian Li, et al.
Published: (2023-01-01)

Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database
by: Bangbei Wan, et al.
Published: (2020-04-01)

Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma
by: Lincheng Li, et al.
Published: (2022-11-01)

Chemokines and their receptors in the esophageal carcinoma tumor microenvironment: key factors for metastasis and progression
by: Pan Liu, et al.
Published: (2025-03-01)

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma
by: Xiong Tian, et al.
Published: (2022-07-01)

Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment
by: Xianyu Zhang, et al.
Published: (2022-07-01)

Physico-chemical characterization of the tumour microenvironment of pancreatic ductal adenocarcinoma
by: Elena García-Gareta, et al.
Published: (2024-06-01)

Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma
by: Jia-Hao Zheng, et al.
Published: (2022-10-01)

Inflammation, microbiota, and pancreatic cancer
by: XiaoLiang Chen, et al.
Published: (2025-02-01)

Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma
by: Haizhen Luo, et al.
Published: (2024-09-01)

Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma
by: Sahar Ghassem-Zadeh, et al.
Published: (2017-06-01)

Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression
by: Xiaojie Bian, et al.
Published: (2019-03-01)

Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment
by: Etienne D. Foucher, et al.
Published: (2018-05-01)

Neutrophil in the Pancreatic Tumor Microenvironment
by: Lin Jin, et al.
Published: (2021-08-01)

Single-cell sequencing and establishment of an 8-gene prognostic model for pancreatic cancer patients
by: Xiao Yu, et al.
Published: (2022-09-01)

The binding and specificity of chemokine binding proteins, through the lens of experiment and computation
by: Lauren E. Stark, et al.
Published: (2022-06-01)

Botanical drugs and their natural compounds: a neglected treasury for inhibiting the carcinogenesis of pancreatic ductal adenocarcinoma
by: Yunfei Dai, et al.
Published: (2024-12-01)